🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12554+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12554 recruiting trials

Phase 1RecruitingNCT05759793

A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

🏥 Nanjing IASO Biotechnology Co., Ltd.📍 1 site📅 Started Mar 2023View details ↗
Phase 1RecruitingNCT05568680

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

👨‍⚕️ Laura Johnson, PhD, Verismo Therapeutics📍 4 sites📅 Started Mar 2023View details ↗
NARecruitingNCT05704530

Liquid Biopsies in Esophageal Cancer

👨‍⚕️ Jeroen Dekervel, MD, Universitaire Ziekenhuizen KU Leuven📍 4 sites📅 Started Mar 2023View details ↗
RecruitingNCT06078098

Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage

🏥 University of Milano Bicocca📍 1 site📅 Started Mar 2023View details ↗
Phase 1RecruitingNCT05791448

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

👨‍⚕️ Anthony B El-Khoueiry, MD, University of Southern California📍 2 sites📅 Started Mar 2023View details ↗
Phase 3RecruitingNCT05482516

Evaluating Novel Therapies in ctDNA Positive GI Cancers

👨‍⚕️ John L. Marshall, MD, Georgetown University📍 3 sites📅 Started Mar 2023View details ↗
EARLY_Phase 1RecruitingNCT06163482

Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis

👨‍⚕️ Jason Winnick, PhD, University of Cincinnati📍 1 site📅 Started Mar 2023View details ↗
Phase 1, PHASE2RecruitingNCT05768529

Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

🏥 Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd📍 2 sites📅 Started Mar 2023View details ↗
NARecruitingNCT05644080

68Ga/177Lu-PSMA Theranostics in Recurrent Grade 3 and Grade 4 Glioma

👨‍⚕️ Tora Solheim, MD/PhD, St. Olavs hospital/NTNU📍 1 site📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05644184

Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

👨‍⚕️ K. Zaman, MBBS, MPH, PhD, FRCP, International Centre for Diarrhoeal Disease Research, Bangladesh📍 1 site📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05453500

Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia

👨‍⚕️ Ryan D. Cassaday, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Mar 2023View details ↗
NARecruitingNCT06995664

Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Management

🏥 Royal Marsden NHS Foundation Trust📍 1 site📅 Started Mar 2023View details ↗
Phase 4RecruitingNCT05550194

VZV in the Enteric Nervous System: Pathogenesis and Consequences

👨‍⚕️ Michael Vaezi, MD, Vanderbilt University Medical Center📍 1 site📅 Started Mar 2023View details ↗
NARecruitingNCT07219537

A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

👨‍⚕️ Guillermo Tearney, M.D., PhD, Massachusetts General Hospital📍 1 site📅 Started Mar 2023View details ↗
RecruitingNCT05705258

A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)

🏥 Bayer📍 1 site📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05530421

Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma

👨‍⚕️ Dickran Kazandjian, MD, University of Miami📍 3 sites📅 Started Mar 2023View details ↗
RecruitingNCT05783869

Study of Bronchiectasis and Associated Cardiovascular Comorbidities

👨‍⚕️ Ahmad Shaddad, Assuit University Faculty of Medicine📍 1 site📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05689645

F573 for Injection for the Treatment of Liver Injury/Failure

🏥 Beijing Continent Pharmaceutical Co, Ltd.📍 10 sites📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05610085

A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

👨‍⚕️ Sonya G Wang, M.D., University of Minnesota📍 5 sites📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05786040

Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder

👨‍⚕️ Timothy J Voorhees, MD, MSCR, Ohio State University Comprehensive Cancer Center📍 3 sites📅 Started Mar 2023View details ↗
← PreviousPage 419 of 628Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →